AEEA-AEEA [BSA]
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally.
Catalog Number | DAG-WT5763B |
Research Area | ELISA |
Size | 5 mg |
Supplier Page | https://www.creative-diagnostics.com/aeea-aeea-bsa-item-dag-wt5763b-131063.html |